Discussion in 'Active Clinical Studies' started by merylg, Sep 28, 2016.
"The Lighthouse Project is the first Phase 2 clinical trial in the world to use modern combination anti-retroviral therapy in patients with MND. The study aims to determine the safety and tolerability of an anti-retroviral therapy “Triumeq” and provide preliminary data on whether it is able to slow down the progression of MND. Triumeq is already used to treat HIV infection safely and effectively. "
"The Lighthouse Project is supported by the Motor Neurone Disease Research Institute of Australia and the Cure for MND Foundation."
You can also try a Google Site Search
Separate names with a comma.